- Single-center, double-blind randomized trial of 60 adults undergoing ACL reconstruction, randomized to CFNB or CACB, with 57 completing the study.
- Both groups received a 20 mL 0.5% ropivacaine loading dose and a 0.2% ropivacaine discharge infusion, comparing continuous femoral with continuous adductor canal blockade.
- Average NRS pain over 48 hours did not differ (estimated effect -0.31 points, p=0.58, 95% CI -1.39 to 0.77).
- In an exploratory analysis, fewer CFNB patients required more than 50 MME over 48 hours (5/28 vs 13/29; p=0.045), which the authors call hypothesis-generating.
Regional
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Preclinical study in male rats with tibial-sparing nerve injury, where SCS responders and nonresponders were classified by how much SCS reduced mechanical hypersensitivity.
- Nonresponders received a subtherapeutic dose of the selective A3 adenosine receptor agonist 2-Cl-IB-MECA alone or combined with acute or repeated SCS.
- The low-dose agonist alone produced minimal pain inhibition, but combined with SCS it restored analgesic responses to both acute and repeated stimulation.
- Repeated SCS reduced microglial activation and shifted microglia toward an anti-inflammatory phenotype, suggesting persistent microglial activation may contribute to SCS nonresponsiveness.
- Retrospective cohort of 147 women aged 65 or older undergoing modified radical mastectomy: 78 received PSPB plus serratus anterior blocks, and 69 had no regional anesthesia.
- At 6 months, the block group had lower QuickDASH scores (7.8 vs 18.7, p<0.001) and better flexion and abduction, but Constant-Murley scores did not differ (p=0.682).
- Persistent stiffness occurred less often with blocks (42.3% vs 69.6%, p=0.002), and regional blockade was an independent protective factor (OR 0.29, 95% CI 0.14-0.59, p=0.001).
- The authors describe an association between regional anesthesia and better functional recovery but state that causality cannot be established given the retrospective design.
- Retrospective single-center observational study of 60 patients with pancreatic cancer pain who received fluoroscopy-guided celiac plexus block, split into CPB-only (n = 34) and CPB plus botulinum toxin A (n = 26) groups.
- The comparison was CPB with BTX versus CPB alone, with pain (NRS), opioid use (MME), and rescue interventions tracked at 4, 8, and 12 weeks.
- The 4-week positive responder rate was 65.4% with BTX versus 8.8% without (p < 0.001), and BTX was independently associated with treatment success (OR = 20.75, p < 0.001).
- The authors conclude BTX may be a non-destructive adjunct to CPB, with no serious adverse events reported, and call for prospective validation.
- Single-center randomized trial of 98 adults undergoing elective unilateral total knee arthroplasty, with patients, surgeons, and outcome assessors blinded.
- Opioid-sparing anesthesia built on esketamine and dexmedetomidine was compared with conventional opioid-based anesthesia, and both groups had a femoral nerve block and multimodal analgesia.
- At 24 hours, QoR-15 was higher with opioid-sparing anesthesia (118.4 vs 113.3; adjusted difference 5.12, 95% CI 0.51-9.74; P=0.029), and this persisted at 48 hours.
- The authors concluded the strategy improved early QoR-15 scores, but the difference did not reach the minimal clinically important difference; lower PONV, lower CRP, and better 1-month Oxford Knee Score were also reported.
- Preclinical study using peripheral nerve injury models to examine PTP1B expression in dorsal root ganglion nociceptors.
- Investigators overexpressed and knocked down PTP1B in nociceptors, and tested Src and GluN2B inhibition on pain-like behavior and synaptic currents.
- Nerve injury sustainedly upregulated PTP1B, mainly in non-peptidergic nociceptors; overexpression produced neuropathic pain-like behaviors and knockdown reversed established hypersensitivity.
- The authors propose PTP1B as an upstream regulator of a presynaptic Src/GluN2B pathway and a potential therapeutic target for neuropathic pain.
- A retrospective quality-improvement review of 15 children under 18 with genetically confirmed CMT who had foot surgery with peripheral nerve blockade, 2017 to 2023.
- Exposure was peripheral nerve blockade across 56 blocks in 34 foot procedures, with popliteal/sciatic blocks in all procedures, often combined with saphenous (50%) or adductor canal (15%) blocks.
- Two limbs (8%) had transient postoperative neurologic deficits and seven limbs (29%) had prolonged block duration, with no permanent neurologic complications observed.
- In exploratory analyses, both outcomes trended or were more frequent in CMT1F (p = 0.057 and p = 0.0037), a subgroup of four patients the authors call hypothesis-generating.
- Narrative review of 63 studies, selected from 558 initial hits and limited to the last 3 years, covering regional anaesthesia for breast surgery.
- Reviews paraspinal blocks such as the erector spinae plane, the thoracic paravertebral block, anterolateral chest wall blocks, the interpectoral block and superficial parasternal intercostal plane block.
- No pooled effect estimates are reported; the authors state that all blocks are superior to local infiltration and that the thoracic paravertebral block is the most reliable.
- The authors note that heterogeneous procedures and outcome measures limit direct comparison between blocks, and they advise tailoring the technique to the operation and the patient.
- Anatomical study plus a bicentric prospective observational study of 80 adults undergoing outpatient foot surgery.
- A two-puncture FIT ankle block was used: a mid-calf injection and a distal transverse injection 5 cm above the medial malleolus, with no comparator group.
- Surgical anesthesia was achieved in 77 of 80 patients (96%), with median sensory and motor block durations of 554 and 600 minutes.
- Rescue IV analgesia was needed in 5% and the complication rate was 0% (95% CI 0 to 3.75%); the authors describe the block as motor-sparing.
- This PRISMA systematic review pooled 19 studies, including sham-controlled trials, active-comparator trials and cohorts, of genicular nerve block and radiofrequency ablation for knee osteoarthritis.
- Pooled random-effects meta-analysis was used where data were homogeneous, and structured narrative synthesis otherwise.
- RFA was associated with larger and more durable pain relief than GNB, often lasting 6-12 months, though most of the comparison evidence is indirect.
- Both approaches reduced pain with no serious procedure-related adverse events reported, and the authors call for head-to-head trials with standardised protocols and longer follow-up.